MAPK Signaling: Oxidative Stress

No Pathway Network information available for MAPK Signaling: Oxidative Stress

Pathways in the MAPK Signaling: Oxidative Stress SuperPath

#	Name	Source	Genes
1	MAPK Signaling: Oxidative Stress	R&D Systems	ARAF ARRB1 ARRB2 ATF2 BAD BAK1 BAX BCL2L1 BCL2L11 BMF BRAF CAMK1 CAMK2A CAMK2D CAMK2G CAMKK1 CREB1 CYBA CYCS FOS FOSB FOSL1 FOXO1 FOXO3 JUN JUNB JUND KRAS MAP2K1 MAP2K2 MAP2K3 MAP2K4 MAP2K6 MAP2K7 MAP3K5 MAPK1 MAPK10 MAPK11 MAPK12 MAPK13 MAPK14 MAPK3 MAPK8 MAPK9 MRAS NFE2L2 PLCG1 PLCG2 PPM1L PPP3CA PPP3R1 PRKCA PRKCB PRKCD PRKCE PRKCG PRKCQ PRKCZ RAF1 RPS6KA4 RPS6KA5 SFN SHC1 SIRT1 SRC STUB1 TP53 TRAF2 TRAF6 TXN TXN2 UBB USP9X YWHAB YWHAE YWHAG YWHAH YWHAQ YWHAZ (see all 79) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	PLCG1	Phospholipase C Gamma 1	Protein Coding	1
2	PLCG2	Phospholipase C Gamma 2	Protein Coding	1
3	CAMKK1	Calcium/Calmodulin Dependent Protein Kinase Kinase 1	Protein Coding	1
4	CAMK1	Calcium/Calmodulin Dependent Protein Kinase I	Protein Coding	1
5	CAMK2A	Calcium/Calmodulin Dependent Protein Kinase II Alpha	Protein Coding	1
6	CAMK2D	Calcium/Calmodulin Dependent Protein Kinase II Delta	Protein Coding	1
7	CAMK2G	Calcium/Calmodulin Dependent Protein Kinase II Gamma	Protein Coding	1
8	KRAS	KRAS Proto-Oncogene, GTPase	Protein Coding	1
9	MRAS	Muscle RAS Oncogene Homolog	Protein Coding	1
10	PRKCA	Protein Kinase C Alpha	Protein Coding	1
11	PRKCB	Protein Kinase C Beta	Protein Coding	1
12	PRKCG	Protein Kinase C Gamma	Protein Coding	1
13	PRKCE	Protein Kinase C Epsilon	Protein Coding	1
14	PRKCD	Protein Kinase C Delta	Protein Coding	1
15	PRKCQ	Protein Kinase C Theta	Protein Coding	1
16	PRKCZ	Protein Kinase C Zeta	Protein Coding	1
17	SRC	SRC Proto-Oncogene, Non-Receptor Tyrosine Kinase	Protein Coding	1
18	RAF1	Raf-1 Proto-Oncogene, Serine/Threonine Kinase	Protein Coding	1
19	ARAF	A-Raf Proto-Oncogene, Serine/Threonine Kinase	Protein Coding	1
20	BRAF	B-Raf Proto-Oncogene, Serine/Threonine Kinase	Protein Coding	1
21	MAP2K1	Mitogen-Activated Protein Kinase Kinase 1	Protein Coding	1
22	MAP2K2	Mitogen-Activated Protein Kinase Kinase 2	Protein Coding	1
23	MAPK3	Mitogen-Activated Protein Kinase 3	Protein Coding	1
24	MAPK1	Mitogen-Activated Protein Kinase 1	Protein Coding	1
25	CYCS	Cytochrome C, Somatic	Protein Coding	1
26	BAX	BCL2 Associated X, Apoptosis Regulator	Protein Coding	1
27	BAK1	BCL2 Antagonist/Killer 1	Protein Coding	1
28	PPM1L	Protein Phosphatase, Mg2+/Mn2+ Dependent 1L	Protein Coding	1
29	PPP3CA	Protein Phosphatase 3 Catalytic Subunit Alpha	Protein Coding	1
30	PPP3R1	Protein Phosphatase 3 Regulatory Subunit B, Alpha	Protein Coding	1
31	TXN	Thioredoxin	Protein Coding	1
32	TXN2	Thioredoxin 2	Protein Coding	1
33	YWHAB	Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Beta	Protein Coding	1
34	YWHAG	Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Gamma	Protein Coding	1
35	YWHAE	Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon	Protein Coding	1
36	YWHAH	Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Eta	Protein Coding	1
37	SFN	Stratifin	Protein Coding	1
38	YWHAQ	Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Theta	Protein Coding	1
39	YWHAZ	Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Zeta	Protein Coding	1
40	MAP3K5	Mitogen-Activated Protein Kinase Kinase Kinase 5	Protein Coding	1
41	TRAF2	TNF Receptor Associated Factor 2	Protein Coding	1
42	TRAF6	TNF Receptor Associated Factor 6	Protein Coding	1
43	USP9X	Ubiquitin Specific Peptidase 9 X-Linked	Protein Coding	1
44	UBB	Ubiquitin B	Protein Coding	1
45	STUB1	STIP1 Homology And U-Box Containing Protein 1	Protein Coding	1
46	ARRB1	Arrestin Beta 1	Protein Coding	1
47	ARRB2	Arrestin Beta 2	Protein Coding	1
48	BCL2L1	BCL2 Like 1	Protein Coding	1
49	BCL2L11	BCL2 Like 11	Protein Coding	1
50	BMF	Bcl2 Modifying Factor	Protein Coding	1
51	BAD	BCL2 Associated Agonist Of Cell Death	Protein Coding	1
52	MAP2K3	Mitogen-Activated Protein Kinase Kinase 3	Protein Coding	1
53	MAP2K6	Mitogen-Activated Protein Kinase Kinase 6	Protein Coding	1
54	MAP2K4	Mitogen-Activated Protein Kinase Kinase 4	Protein Coding	1
55	MAP2K7	Mitogen-Activated Protein Kinase Kinase 7	Protein Coding	1
56	MAPK8	Mitogen-Activated Protein Kinase 8	Protein Coding	1
57	MAPK9	Mitogen-Activated Protein Kinase 9	Protein Coding	1
58	MAPK10	Mitogen-Activated Protein Kinase 10	Protein Coding	1
59	MAPK14	Mitogen-Activated Protein Kinase 14	Protein Coding	1
60	MAPK11	Mitogen-Activated Protein Kinase 11	Protein Coding	1
61	MAPK12	Mitogen-Activated Protein Kinase 12	Protein Coding	1
62	MAPK13	Mitogen-Activated Protein Kinase 13	Protein Coding	1
63	SHC1	SHC Adaptor Protein 1	Protein Coding	1
64	NFE2L2	NFE2 Like BZIP Transcription Factor 2	Protein Coding	1
65	FOXO1	Forkhead Box O1	Protein Coding	1
66	FOXO3	Forkhead Box O3	Protein Coding	1
67	SIRT1	Sirtuin 1	Protein Coding	1
68	JUN	Jun Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	1
69	JUNB	JunB Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	1
70	JUND	JunD Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	1
71	FOS	Fos Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	1
72	FOSB	FosB Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	1
73	FOSL1	FOS Like 1, AP-1 Transcription Factor Subunit	Protein Coding	1
74	CYBA	Cytochrome B-245 Alpha Chain	Protein Coding	1
75	RPS6KA5	Ribosomal Protein S6 Kinase A5	Protein Coding	1
76	RPS6KA4	Ribosomal Protein S6 Kinase A4	Protein Coding	1
77	TP53	Tumor Protein P53	Protein Coding	1
78	ATF2	Activating Transcription Factor 2	Protein Coding	1
79	CREB1	CAMP Responsive Element Binding Protein 1	Protein Coding	1

Disorders associated with MAPK Signaling: Oxidative Stress SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Cardiofaciocutaneous syndrome 1	Enrichment	BRAF, KRAS, MAP2K1, MAP2K2	8.96
2	Cardiofaciocutaneous syndrome	Enrichment	BRAF, KRAS, MAP2K1, MAP2K2	8.96
3	Noonan syndrome 1	Enrichment	BRAF, KRAS, MAP2K1, MAP2K2, MRAS, RAF1	8.52
4	Rasopathy	Enrichment	BRAF, KRAS, MAP2K1, MAP2K2, MRAS, RAF1	8.17
5	Noonan syndrome and noonan-related syndrome	Enrichment	BRAF, KRAS, MAP2K1, MAP2K2, RAF1	7.77
6	Gallbladder cancer	Enrichment	BRAF, KRAS, TP53	5.18
7	Pilomyxoid astrocytoma	Enrichment	BRAF, KRAS, RAF1	5.18
8	Lung non-small cell carcinoma	Enrichment	BRAF, KRAS, MAP2K1	4.52
9	Lung cancer susceptibility 3	Enrichment	BRAF, KRAS, TP53	4.18
10	Langerhans cell histiocytosis	Enrichment	BRAF, MAP2K1	4.00
11	Colorectal cancer	Enrichment	BAX, BRAF, NFE2L2, SRC, TP53	3.82
12	Diffuse large b-cell lymphoma	Enrichment	BRAF, FOXO1, TP53	3.76
13	Thyroid cancer, nonmedullary, 1	Enrichment	BRAF, TP53	3.70
14	Lung sarcomatoid carcinoma	Enrichment	KRAS, TP53	3.70
15	Noonan syndrome with multiple lentigines	Enrichment	BRAF, RAF1	3.70
16	Rhabdomyosarcoma 2	Enrichment	FOXO1, TP53	3.48
17	Histiocytoid hemangioma	Enrichment	FOS, FOSB	3.48
18	Breast adenocarcinoma	Enrichment	KRAS, TP53	3.31
19	Capillary malformation-arteriovenous malformation 1	Enrichment	KRAS, MAP2K1	3.16
20	Noonan syndrome 3	Enrichment	KRAS, RAF1	3.16
21	Lung cancer	Enrichment	BRAF, KRAS, NFE2L2	3.08
22	Melanocytic nevus syndrome, congenital	Enrichment	BRAF, RAF1	3.04
23	Lymphoma, non-hodgkin, familial	Enrichment	BRAF, TP53	3.04
24	Breast cancer	Enrichment	JUN, KRAS, SHC1, TP53	3.02
25	Primary hyperaldosteronism	Enrichment	BRAF, TP53	2.93
26	Specific learning disability	Enrichment	MAPK1, YWHAG	2.75
27	Lip and oral cavity carcinoma	Enrichment	BRAF, TP53	2.67
28	Autosomal dominant non-syndromic intellectual disability	Enrichment	CAMK2A, PPP3CA, YWHAZ	2.51
29	Myeloma, multiple	Enrichment	BRAF, KRAS, TP53	2.37
30	Arteriovenous malformations of the brain	Enrichment	BRAF, KRAS	2.27
31	Granulomatous disease, chronic, autosomal recessive, 4	Enrichment	CYBA	2.23
32	Oculoectodermal syndrome	Enrichment	KRAS	2.23
33	Pallister-killian syndrome	Enrichment	ARAF	2.23
34	Intellectual developmental disorder, x-linked 99	Enrichment	USP9X	2.23
35	Noonan syndrome 5	Enrichment	RAF1	2.23
36	Melorheostosis, isolated	Enrichment	MAP2K1	2.23
37	Noonan syndrome 7	Enrichment	BRAF	2.23
38	Leopard syndrome 3	Enrichment	BRAF	2.23
39	Cardiomyopathy, dilated, 1nn	Enrichment	RAF1	2.23
40	Cardiofaciocutaneous syndrome 3	Enrichment	MAP2K1	2.23
41	Autoimmune lymphoproliferative syndrome, type iii	Enrichment	PRKCD	2.23
42	Noonan syndrome 11	Enrichment	MRAS	2.23
43	Noonan syndrome 13	Enrichment	MAPK1	2.23
44	Combined oxidative phosphorylation deficiency 29	Enrichment	TXN2	2.23
45	Intellectual developmental disorder, autosomal recessive 63	Enrichment	CAMK2A	2.23
46	Developmental and epileptic encephalopathy 91	Enrichment	PPP3CA	2.23
47	Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development	Enrichment	PPP3CA	2.23
48	Bone marrow failure syndrome 5	Enrichment	TP53	2.23
49	Immune dysregulation, autoimmunity, and autoinflammation	Enrichment	PLCG1	2.23
50	Immunodeficiency, developmental delay, and hypohomocysteinemia	Enrichment	NFE2L2	2.23
51	Papilloma of choroid plexus	Enrichment	TP53	2.23
52	Basal cell carcinoma 7	Enrichment	TP53	2.23
53	Intellectual developmental disorder, x-linked 99, syndromic, female-restricted	Enrichment	USP9X	2.23
54	Anaplastic thyroid carcinoma	Enrichment	TP53	2.23
55	Cardiofaciocutaneous syndrome 2	Enrichment	KRAS	2.23
56	Lymphangioma	Enrichment	BRAF	2.23
57	Thrombocytopenia 4	Enrichment	CYCS	2.23
58	Phace association	Enrichment	BRAF	2.23
59	Spinocerebellar ataxia 14	Enrichment	PRKCG	2.23
60	Melorheostosis	Enrichment	MAP2K1	2.23
61	Leopard syndrome 2	Enrichment	RAF1	2.23
62	Cardiofaciocutaneous syndrome 4	Enrichment	MAP2K2	2.23
63	Autoinflammation, antibody deficiency, and immune dysregulation	Enrichment	PLCG2	2.23
64	Ductal carcinoma in situ	Enrichment	TP53	2.23
65	Familial cold autoinflammatory syndrome 3	Enrichment	PLCG2	2.23
66	Developmental and epileptic encephalopathy 56	Enrichment	YWHAG	2.23
67	Thrombocytopenia 6	Enrichment	SRC	2.23
68	Intellectual developmental disorder, autosomal dominant 53	Enrichment	CAMK2A	2.23
69	Trigonitis	Enrichment	RAF1	2.23
70	Thyroid gland undifferentiated carcinoma	Enrichment	TP53	2.23
71	Intellectual developmental disorder, autosomal dominant 59	Enrichment	CAMK2G	2.23
72	Small-cell carcinoma of the ovary of hypercalcemic type	Enrichment	TP53	2.23
73	Female-restricted syndromic x-linked intellectual disability 99	Enrichment	USP9X	2.23
74	Diffuse pediatric-type high-grade glioma, h3-wildtype and idh-wildtype	Enrichment	TP53	2.23
75	Congenital pulmonary airway malformation	Enrichment	KRAS	2.23
76	Choroid plexus cancer	Enrichment	TP53	2.23
77	Syringocystadenoma papilliferum	Enrichment	BRAF	2.23
78	Pleomorphic xanthoastrocytoma	Enrichment	TP53	2.23
79	Ganglioglioma	Enrichment	BRAF	2.23
80	Nongerminomatous germ cell tumor	Enrichment	BRAF	2.23
81	Phace syndrome	Enrichment	BRAF	2.23
82	Classic hairy cell leukemia	Enrichment	BRAF	2.23
83	Distal 17p13.3 microdeletion syndrome	Enrichment	YWHAE	2.23
84	Pancreatic cancer	Enrichment	KRAS, TP53	2.04
85	Adrenocortical carcinoma, hereditary	Enrichment	TP53	1.94
86	Cervical cancer	Enrichment	TP53	1.94
87	Pulmonic stenosis	Enrichment	BRAF	1.94
88	Histiocytoma, angiomatoid fibrous	Enrichment	CREB1	1.94
89	Encephalocraniocutaneous lipomatosis	Enrichment	KRAS	1.94
90	Ras-associated autoimmune leukoproliferative disorder	Enrichment	KRAS	1.94
91	Lymphoma, hodgkin, classic	Enrichment	TP53	1.94
92	Spinocerebellar ataxia 48	Enrichment	STUB1	1.94
93	Congenital fibrosarcoma	Enrichment	TP53	1.94
94	Li-fraumeni syndrome 1	Enrichment	TP53	1.94
95	Sarcoma	Enrichment	TP53	1.94
96	Cervix carcinoma	Enrichment	TP53	1.94
97	Hodgkin's lymphoma	Enrichment	TP53	1.94
98	Pleomorphic rhabdomyosarcoma	Enrichment	TP53	1.94
99	Tafro syndrome	Enrichment	MAP2K2	1.94
100	Submucosal cleft palate	Enrichment	UBB	1.94
101	Cleft hard palate	Enrichment	UBB	1.94
102	Bladder cancer	Enrichment	KRAS, TP53	1.91
103	Differentiated thyroid carcinoma	Enrichment	BRAF, KRAS	1.91
104	Ataxia-telangiectasia	Enrichment	BRAF	1.76
105	Autoimmune polyendocrine syndrome, type i, with or without reversible metaphyseal dysplasia	Enrichment	CYBA	1.76
106	Uvula, bifid	Enrichment	UBB	1.76
107	Osteogenic sarcoma	Enrichment	TP53	1.76
108	Cleft soft palate	Enrichment	UBB	1.76
109	Nasopharyngeal carcinoma	Enrichment	TP53	1.76
110	Miller-dieker lissencephaly syndrome	Enrichment	YWHAE	1.76
111	Chromosome 17p13.3, centromeric, duplication syndrome	Enrichment	YWHAE	1.76
112	Tethered spinal cord syndrome	Enrichment	BRAF	1.76
113	Atypical teratoid rhabdoid tumor	Enrichment	TP53	1.76
114	Anaplastic astrocytoma	Enrichment	TP53	1.76
115	Squamous cell carcinoma	Enrichment	TP53	1.76
116	T-cell acute lymphoblastic leukemia	Enrichment	BAX	1.76
117	Adenocarcinoma	Enrichment	TP53	1.76
118	Bone osteosarcoma	Enrichment	TP53	1.76
119	Autoimmune polyendocrine syndrome type 1	Enrichment	CYBA	1.76
120	Melanoma of soft tissue	Enrichment	CREB1	1.76
121	Hyperpigmentation of the skin	Enrichment	USP9X	1.76
122	Leukemia, acute myeloid	Enrichment	KRAS, TP53	1.65
123	Schimmelpenning-feuerstein-mims syndrome	Enrichment	KRAS	1.64
124	Diffuse gastric and lobular breast cancer syndrome	Enrichment	KRAS	1.64
125	Small cell cancer of the lung	Enrichment	TP53	1.64
126	Neurofibromatosis-noonan syndrome	Enrichment	MAP2K2	1.64
127	Chromosome 22q11.2 deletion syndrome, distal	Enrichment	MAPK1	1.64
128	Congenital generalized lipodystrophy	Enrichment	FOS	1.64
129	Chronic myelogenous leukemia, bcr-abl1 positive	Enrichment	KRAS	1.64
130	Hereditary ataxia	Enrichment	PRKCG	1.64
131	Embryonal rhabdomyosarcoma	Enrichment	TP53	1.64
132	Craniopharyngioma	Enrichment	BRAF	1.64
133	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	Enrichment	YWHAZ	1.64
134	Pilocytic astrocytoma	Enrichment	KRAS	1.64
135	Newborn respiratory distress syndrome	Enrichment	BRAF	1.64
136	Pseudomyogenic hemangioendothelioma	Enrichment	FOSB	1.64
137	Gastric cancer	Enrichment	KRAS, TP53	1.59
138	Hereditary breast carcinoma	Enrichment	KRAS, TP53	1.57
139	Ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant	Enrichment	TRAF6	1.54
140	Lymphoma	Enrichment	TP53	1.54
141	Acute megakaryocytic leukemia	Enrichment	TP53	1.54
142	Autosomal thrombocytopenia with normal platelets	Enrichment	CYCS	1.54
143	Endometrial stromal sarcoma	Enrichment	YWHAE	1.54
144	Thrombocytopenia	Enrichment	CYCS, SRC	1.50
145	Li-fraumeni syndrome	Enrichment	TP53	1.46
146	Wilms tumor 5	Enrichment	BRAF	1.46
147	Spinocerebellar ataxia, autosomal recessive 16	Enrichment	STUB1	1.46
148	Adrenocortical carcinoma	Enrichment	TP53	1.46
149	Lung squamous cell carcinoma	Enrichment	KRAS	1.46
150	Kidney clear cell sarcoma	Enrichment	YWHAE	1.46
151	Esophageal cancer	Enrichment	TP53	1.40
152	Nevus, epidermal	Enrichment	KRAS	1.40
153	Thyroid cancer, nonmedullary, 2	Enrichment	BRAF	1.40
154	Myelofibrosis	Enrichment	SRC	1.40
155	Squamous cell carcinoma, head and neck	Enrichment	TP53	1.40
156	Leukemia, chronic myeloid	Enrichment	KRAS	1.40
157	Essential thrombocythemia	Enrichment	TP53	1.40
158	Follicular thyroid carcinoma	Enrichment	BRAF	1.40
159	B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)	Enrichment	TP53	1.40
160	Hereditary breast ovarian cancer syndrome	Enrichment	KRAS, TP53	1.39
161	Undetermined early-onset epileptic encephalopathy	Enrichment	PPP3CA, YWHAG	1.38
162	Glioma susceptibility 1	Enrichment	TP53	1.34
163	Lennox-gastaut syndrome	Enrichment	MAPK10	1.34
164	Cardiomyopathy, familial hypertrophic, 4	Enrichment	BRAF	1.29
165	Inflammatory bowel disease 1	Enrichment	PRKCQ	1.29
166	Arteriovenous malformation	Enrichment	MAP2K1	1.29
167	Adult hepatocellular carcinoma	Enrichment	TP53	1.29
168	Chronic granulomatous disease	Enrichment	CYBA	1.29
169	Ventricular septal defect	Enrichment	BRAF	1.29
170	Leukemia, chronic lymphocytic	Enrichment	TP53	1.25
171	Myopathy, x-linked, with excessive autophagy	Enrichment	MAP2K1	1.25
172	Melanoma	Enrichment	BRAF	1.25
173	Familial colorectal cancer	Enrichment	TP53	1.25
174	Myelodysplastic syndrome	Enrichment	TP53	1.21
175	Juvenile myelomonocytic leukemia	Enrichment	KRAS	1.17
176	Chromosome 1p36 deletion syndrome	Enrichment	PRKCZ	1.14
177	Osteoporosis	Enrichment	SRC	1.10
178	Dilated cardiomyopathy	Enrichment	BRAF, RAF1	1.10
179	Wilms tumor 1	Enrichment	BRAF	1.08
180	Lynch syndrome	Enrichment	KRAS	1.08
181	Rhabdomyosarcoma	Enrichment	TP53	1.05
182	Gliosarcoma	Enrichment	TP53	1.05
183	Melanoma, cutaneous malignant 1	Enrichment	BRAF	1.02
184	Dandy-walker syndrome	Enrichment	BRAF	1.02
185	Giant cell glioblastoma	Enrichment	TP53	1.02
186	Heart, malformation of	Enrichment	MAPK1	1.00
187	Hepatoblastoma	Enrichment	TP53	0.94
188	Ovarian cancer	Enrichment	KRAS, TP53	0.93
189	Hepatocellular carcinoma	Enrichment	TP53	0.92
190	Diamond-blackfan anemia 1	Enrichment	TP53	0.90
191	Cardiomyopathy, familial hypertrophic, 1	Enrichment	RAF1	0.88
192	Prostate cancer	Enrichment	TP53	0.81
193	Microcephaly	Enrichment	MAPK1, YWHAG	0.79
194	Non-immune hydrops fetalis	Enrichment	KRAS	0.78
195	Familial hypertrophic cardiomyopathy	Enrichment	RAF1	0.76
196	Left ventricular noncompaction	Enrichment	RAF1	0.73
197	Non-syndromic x-linked intellectual disability	Enrichment	USP9X	0.72
198	Diamond-blackfan anemia	Enrichment	TP53	0.72
199	Familial isolated dilated cardiomyopathy	Enrichment	RAF1	0.57
200	Autism	Enrichment	CAMK2G	0.46
201	Autism spectrum disorder	Enrichment	MAP2K1	0.33
202	Inherited cancer-predisposing syndrome	Enrichment	TP53	0.27

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

MAPK Signaling: Oxidative Stress

Pathway Network for MAPK Signaling: Oxidative Stress

Member Pathways for MAPK Signaling: Oxidative Stress

Pathways in the MAPK Signaling: Oxidative Stress SuperPath

Associated Genes for MAPK Signaling: Oxidative Stress

Associated Disorders for MAPK Signaling: Oxidative Stress

Disorders associated with MAPK Signaling: Oxidative Stress SuperPath

STRING Interaction Network for MAPK Signaling: Oxidative Stress

Sources for MAPK Signaling: Oxidative Stress